Dementias Terminated Phase 2 / 3 Trials for Megestrol acetate (DB00351)

Also known as: Dementia / Dementia NOS / Amentia

IndicationStatusPhase
DBCOND0060453 (Dementias)Terminated2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00503516Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia PatientsTreatment